Automating Neurology Claim Status Tracking for Complex Neuro Therapies

Effective **neurology claim status tracking** is critical for managing the high-value, complex claims common in neurological care, from specialty drugs to advanced diagnostics. Klivira automates this vital revenue cycle function, ensuring proactive visibility and resolution.

Neurology practices face unique challenges in claim management due to high-cost specialty pharmaceuticals, frequent re-authorizations, and intricate documentation requirements. Manual claim status checks lead to significant administrative burden and increased risk of timely-filing breaches. Klivira's platform provides a comprehensive solution, integrating directly with your EMR to automate status updates and prevent revenue leakage.

The Unique Demands of Neurology Claims

Neurology claims often involve high-cost disease-modifying therapies for conditions like Multiple Sclerosis (MS), targeted migraine biologics, and advanced imaging such as brain MRIs. These claims are frequently subject to complex prior authorization (PA) requirements, periodic re-authorization cycles, and specific clinical documentation guided by frameworks like AAN Practice Guidelines.

Key Neurology Claim Categories Requiring Proactive Status Tracking

MS disease-modifying therapies (e.g., ocrelizumab, natalizumab)
CGRP migraine prevention biologics (e.g., erenumab, galcanezumab)
Alzheimer's disease therapeutics (e.g., lecanemab)
Advanced imaging (e.g., amyloid PET, advanced brain MRI)
Neuromodulation procedures (e.g., Deep Brain Stimulation - DBS)
Botox for chronic migraine and spasticity

Bridging the Gap: From Prior Authorization to Claim Resolution

A common challenge in neurology is the disconnect between a meticulously secured prior authorization and its corresponding claim. Klivira's platform maintains a clear linkage between the initial PA approval and the submitted claim, identifying discrepancies where authorized services may not align with billed services. This ensures that the extensive work put into PA for drugs like lecanemab or onasemnogene abeparvovec directly translates to proper claim adjudication.

Klivira's Automated Approach to Neurology Claim Status

Klivira automates the entire claim status tracking workflow, eliminating the manual overhead associated with payer portal polling and phone calls. Our system performs automated X12 277 inquiries on configurable schedules, prioritizing claims in "pending" or "review" status. This proactive approach is essential for managing the high volume of specialty drug claims and re-authorizations prevalent in neurology.

Core Capabilities for Neurology Revenue Cycle Teams

Automated X12 277 polling and X12 835 ingestion for comprehensive status updates.
FHIR ClaimResponse integration for payers supporting Da Vinci PAS workflows.
Normalized claim status taxonomy to interpret payer-specific codes consistently.
Configurable escalation rules for claims pending beyond defined thresholds, preventing timely-filing breaches.
Direct linkage of prior authorizations to submitted claims for end-to-end visibility.
Alerting on aged claims that require immediate follow-up, critical for high-value neuro therapies.

EMR Integration and Payer Connectivity for Neurology Practices

Klivira seamlessly integrates with leading EMR systems, pulling relevant clinical and billing data to inform claim status inquiries and updates. This ensures that documentation requirements for complex neurology PAs, such as McDonald criteria for MS DMTs or amyloid confirmation for AD therapeutics, are consistently reflected in the claim lifecycle. Our robust payer connectivity covers a broad spectrum of health plans and clearinghouses, streamlining interactions across the diverse landscape of neurology payers.

Frequently asked questions

How does Klivira handle the specific complexities of neurology claims like MS DMTs or advanced imaging?

Klivira's platform is designed to manage the specific nuances of neurology claims by linking prior authorizations for high-cost drugs like MS DMTs and advanced imaging to their corresponding claims. We normalize payer status responses, providing clarity on complex denials related to step therapy for CGRP biologics or documentation for Alzheimer's therapeutics, enabling targeted follow-up.

Can Klivira track re-authorization claims for chronic neurology treatments?

Yes, Klivira tracks re-authorization claims for chronic neurology treatments, such as ongoing MS DMTs or Botox for chronic migraine. Our system can be configured to aggressively poll for status updates on these recurring claims, ensuring continuous coverage and minimizing disruptions to patient care.

How does Klivira prevent neurology claims from being denied due to timely-filing limits?

Klivira prevents timely-filing denials by implementing configurable escalation rules for neurology claims that remain in "pending" or "review" status beyond set thresholds. This proactive alerting system ensures that revenue cycle teams can address stuck claims, such as those for Deep Brain Stimulation (DBS) or complex gene therapies, before they breach critical submission deadlines.

What role does Klivira's PA-to-claim linkage play in optimizing neurology revenue?

The PA-to-claim linkage is crucial for optimizing neurology revenue by ensuring that the prior authorization secured for high-value services, like lecanemab infusions or advanced MRI, is correctly applied to the final claim. This linkage helps identify and reconcile discrepancies, reducing the risk of denials and underpayments that can significantly impact a neurology practice's financial health.

Does Klivira integrate with EMRs to pull neurology-specific documentation for claim status?

Klivira integrates with EMRs to access relevant clinical documentation, such as McDonald criteria for MS, headache diaries for CGRP migraine biologics, or MRI findings for advanced imaging. While this data primarily supports the PA process, its availability helps ensure claims are submitted with accurate information, reducing the likelihood of status delays or denials that require manual intervention.